Back to Search
ROBERT CHRISTENSON, D.O.
D.O.
Surgery Physician
NPI: 1427419506IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
4313(TN)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryGENERAL SURGERY
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 2016
Research & Publications (20)
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
PMID 18988754·Clin Chem·2009
8-other
Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up.
PMID 19416541·BMC Med Phys·2009
8-other
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
PMID 19414634·Circulation·2009
8-other
Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function.
PMID 19515720·Eur J Heart Fail·2009
4-observational
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.
PMID 19106185·Clin Chem·2009
6-review
Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.
PMID 19523464·Clin Biochem·2009
8-other
B-type natriuretic peptide (BNP)/NT-proBNP and renal function: is the controversy over?
PMID 19460836·Clin Chem·2009
8-other
Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms.
PMID 18929551·Clin Biochem·2009
6-review
A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial.
PMID 18691791·Ann Emerg Med·2009
4-observational
Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system.
PMID 19303402·Clin Biochem·2009
4-observational
What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care?
PMID 18847367·Clin Chem Lab Med·2008
6-review
Amino-terminal pro-B-type natriuretic peptide: analytic considerations.
PMID 18243867·Am J Cardiol·2008
6-review
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
PMID 18048022·Clin Biochem·2008
6-review
Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure.
PMID 19033018·Am Heart J·2008
8-other
Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease.
PMID 18383049·Clin Cardiol·2008
8-other
Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.
PMID 18310156·Clin Chem·2008
8-other
Special section: utilization of B-type natriuretic peptide and N-terminal B-type natriuretic peptide in laboratory medicine. Foreword.
PMID 18280817·Clin Biochem·2008
8-other
Evaluating new diagnostic technologies: perspectives in the UK and US.
PMID 18755905·Clin Chem·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 327 BEACH 19TH ST
FAR ROCKAWAY, NY 11691 - Phone
- (718) 869-7256
Quick Facts
- NPI
- 1427419506
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile